OxStem
Oxford
About OxStem
OxStem plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body. Building on decades of experience in medicinal chemistry, OxStem will design drugs that can programme resident stem and stem-like cells in situ to treat currently untreatable age-related conditions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $24.4M
- Last round: Series Unknown (May 2016)
- Website: oxstem.co.uk
- Phone: +44 0 20 7630 2180
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/oxstem-216889 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.